Status:

COMPLETED

The Health Benefits of Conjugated Linoleic Acid (CLA) for Asthma & Allergy

Lead Sponsor:

University of British Columbia

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

Canadian Lung Association/British Columbia Lung Association

Conditions:

Asthma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Conjugated linoleic acids (CLA) are naturally occurring free fatty acids derived from the tissues and milk of ruminant animals such as cows. CLA has multiple biological properties including regulation...

Detailed Description

Background and Purpose You are being invited to participate in a study of the effects of a natural supplement, conjugated linoleic acid (CLA), on allergy and asthma. Previous studies show that CLA may...

Eligibility Criteria

Inclusion

  • Mild asthma - FEV1 \> 70% predicted Positive methacholine challenge

Exclusion

  • \-

Key Trial Info

Start Date :

May 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2004

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00876356

Start Date

May 1 2002

End Date

September 1 2004

Last Update

April 6 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St. Paul's Hospital

Vancouver, British Columbia, Canada, V6Z 1Y6